Puberty-suppression prescribing restriction clarified
The prescribing restriction applies only to puberty suppression for children and teenagers with gender incongruence or dysphoria.
Medicines (Restriction on Prescribing Gonadotropin-releasing Hormone Analogues) Amendment Regulations (No 2) 2025 · Starts 19 Dec 2025
What's changing
- The prescribing restriction now applies only to puberty suppression for children and adolescents with gender incongruence or gender dysphoria.
- The restriction no longer covers adults undergoing gender transition.
Who's affected
Children and adolescents seeking puberty suppression, their families, and authorised prescribers are affected; adults undergoing gender transition are no longer covered by this restriction.
When
The changes took effect on 19 December 2025.
Background
The government says the earlier restriction was too broad because it could cover adults as well as puberty suppression for children and adolescents. These regulations clarify what the restriction applies to.